SURG Surgepays Inc

Price (delayed)

$0.1731

Market cap

$9.16M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.53

Enterprise value

$24.68M

?
Relative Growth: Rel. Growth: 61
Relative Strength: Rel. Strength: 1
Relative Valuation: Rel. Valuation: 41
Relative Profitability: Rel. Profitability: 10

Synergetics USA, Inc. (Synergetics USA) is a supplier of precision surgical devices. The Company's primary focus is on the disciplines of ophthalmology and neurosurgery. The Company's product lines focus upon ...

Highlights
The company's revenue has surged by 84% YoY and by 8% QoQ
The gross margin has surged by 71% year-on-year and by 20% since the previous quarter
The quick ratio has dropped by 64% year-on-year but it has increased by 16% since the previous quarter
Surgepays's debt has surged by 78% YoY and by 15% QoQ

Key stats

What are the main financial stats of SURG

SURG stock price

How has the Surgepays stock price performed over time
Intraday
5.23%
1 week
4.21%
1 month
-42.57%
1 year
-93.97%
YTD
-89.63%
QTD
-52.05%

Financial performance

How have Surgepays's revenue and profit performed over time
Revenue
$67.06M
Gross profit
-$13.11M
Operating income
-$27.49M
Net income
-$32.11M
Gross margin
-19.6%
Net margin
-47.9%
The company's revenue has surged by 84% YoY and by 8% QoQ
The gross margin has surged by 71% year-on-year and by 20% since the previous quarter
Surgepays's operating margin has surged by 69% YoY and by 32% QoQ
Surgepays's net margin has surged by 64% YoY and by 26% QoQ

Price vs fundamentals

How does SURG's price correlate with its fundamentals

Growth

What is Surgepays's growth rate over time

Valuation

What is Surgepays stock price valuation
P/E
N/A
P/B
N/A
P/S
0.07
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.37
Surgepays's EPS has increased by 39% YoY and by 21% from the previous quarter
Surgepays's equity has increased by 13% QoQ
SURG's P/S is 88% below its 5-year quarterly average of 0.6 and 86% below its last 4 quarters average of 0.5
The company's revenue has surged by 84% YoY and by 8% QoQ

Efficiency

How efficient is Surgepays business performance
Surgepays's ROS has soared by 68% YoY and by 29% from the previous quarter
Surgepays's ROA has plunged by 52% YoY but it has increased by 9% from the previous quarter

Dividends

What is SURG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SURG.

Financial health

How did Surgepays financials performed over time
Surgepays's total assets is 69% lower than its total liabilities
Surgepays's total liabilities has surged by 98% YoY but it has decreased by 10% QoQ
The current ratio has plunged by 83% YoY and by 30% from the previous quarter
Surgepays's debt is 187% higher than its equity
Surgepays's debt to equity has shrunk by 101% YoY and by 34% QoQ
Surgepays's debt has surged by 78% YoY and by 15% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.